Your browser doesn't support javascript.
loading
Blood donation and risk of polycythemia vera.
Edgren, Gustaf; Nyrén, Olof; Hultcrantz, Malin; Nielsen, Kaspar Rene; Pedersen, Ole B V; Björkholm, Magnus; Rostgaard, Klaus; Hjalgrim, Henrik.
Afiliação
  • Edgren G; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Nyrén O; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Hultcrantz M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Nielsen KR; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Pedersen OB; Division of Hematology, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Björkholm M; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
  • Rostgaard K; Department of Clinical Immunology, Naestved Hospital, Naestved, Denmark.
  • Hjalgrim H; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
Transfusion ; 56(6 Pt 2): 1622-7, 2016 06.
Article em En | MEDLINE | ID: mdl-26830533
ABSTRACT

BACKGROUND:

It has been suggested that blood donors could have an increased risk of polycythemia vera (PV). However, no study has assessed whether frequent donors have a higher PV risk than less frequent donors. STUDY DESIGN AND

METHODS:

From the Scandinavian Donations and Transfusions (SCANDAT2) database, we established a cohort of blood donors who had donated whole blood at least once between 1980 and 2012. Within this cohort we first assessed the risk of PV, comparing the donors to the general population using standardized incidence ratios (SIRs) with corresponding 95% confidence intervals (CIs). To assess the association between frequency of blood donation and risk of PV we then conducted a case-control study nested within the cohort, where we compared prior donation activity among donors who were diagnosed with PV and matched controls. Here odds ratios (ORs) were used as measures of relative risk comparing donors with different donation frequency.

RESULTS:

Among 1.4 million donors in the cohort a total of 271 donors developed PV, yielding a SIR of 1.00 (95% CI, 0.89-1.13) compared to the general population. The nested case-control study showed no association between donation frequency and risk of PV. The OR of PV comparing donors who had made at least 33 donations in the period from 3 to 22 years before diagnosis of the case, to donors with one to eight donations in the same period was 1.01 (95% CI, 0.51-1.97).

CONCLUSIONS:

We find no evidence of excess risk of PV among blood donors or of an association between donation frequency and PV risk.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Policitemia Vera / Doadores de Sangue Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Transfusion Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Policitemia Vera / Doadores de Sangue Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Transfusion Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia